{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day]

RxCUI
1020155
RxNorm name
{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day]
Display name
INTROVALE 91 DAY (Pack)
Full name
{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day]
Term type
BPCK
Status
Active
Strength
mixed
Dose form
Pack
Route
Pack
Updated
2026-11-16 14:53:39

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
112010
Active start
112010
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
ethinyl estradiol0.03 MG / 1 EACHethinyl estradiolethinyl estradiol
levonorgestrel0.15 MG / 1 EACHlevonorgestrellevonorgestrel
inert ingredients1 MG / 1 EACHinert ingredientsinert ingredients

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Pack746839

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
ethinyl estradiol4124
levonorgestrel6373
inert ingredients748794

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRIntrovale 91 Day Pack1NAMES
RxNorm Name{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day]1NAMES
RxNorm SynonymIntrovale 91 Day Pack1NAMES
TTYBPCK1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI10201551CODES
MMSL_CODEBD130141CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
70700-117-8770700-117Introvale Levonorgestrel and Ethinyl EstradiolXiromed, LLC.ANDA079064
70700-208-8870700-208INTROVALE Levonorgestrel and Ethinyl Estradiol tabletsXiromed LLCANDA200490

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA07906470700-117Introvale Levonorgestrel and Ethinyl EstradiolANDAXiromed, LLC.
ANDA20049070700-208INTROVALE Levonorgestrel and Ethinyl Estradiol tabletsANDAXiromed LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 5 matching rows.

NDC11, Source, Active table
NDC11SourceActive
70700011787rxnav_ndcsyes
70700020887rxnav_ndcsyes
70700020888rxnav_ndcsyes
00781558436rxnav_historical
00781558491rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INTROVALELEVONORGESTREL AND ETHINYL ESTRADIOL TABLETSXiromed LLC24abb5e1-5be4-87e7-404c-d8c2db25ffd02024-10-15Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 70700-208-88
ndc (product): 70700-208
ndc11 (package): 70700020887
ndc11 (package): 70700020888
rxcui: 1020155
IntrovaleLEVONORGESTREL AND ETHINYL ESTRADIOLXiromed, LLC.f5bc2427-3a18-e3e6-a058-210688e9c4462022-06-09Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 70700-117-87
ndc (product): 70700-117
ndc11 (package): 70700011787
rxcui: 1020155

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f5bc2427-3a18-e3e6-a058-210688e9c446{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day] [BPCK] · Introvale 91 Day Pack [PSN] · Introvale 91 Day Pack [SY]37These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE. Introvale ® Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg for oral use Initial U.S. Approval: 198220220609
24abb5e1-5be4-87e7-404c-d8c2db25ffd0{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Introvale 91 Day] [BPCK] · Introvale 91 Day Pack [PSN] · Introvale 91 Day Pack [SY]31These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE . INTROVALE ® (levonorgestrel and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 198220241015

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
24abb5e1-5be4-87e7-404c-d8c2db25ffd0These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE . INTROVALE ® (levonorgestrel and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1982Xiromed LLC20241015
f5bc2427-3a18-e3e6-a058-210688e9c446These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE. Introvale ® Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg for oral use Initial U.S. Approval: 1982Xiromed, LLC. | XIROMED PHARMA ESPANA, S.L. | Aspen Oss B.V.20220609
60a47d8c-d95f-4f81-9706-4954921fabbbNational Council for Prescription Drug Programs20130211
7e60a323-6156-4ee5-9bed-11f1e5a2f405National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCG03ADEmergency contraceptivesATC1-4levonorgestrel
ATCL02AAEstrogensATC1-4ethinyl estradiol
ATCG03CANatural and semisynthetic estrogens, plainATC1-4ethinyl estradiol
ATCG03ACProgestogensATC1-4levonorgestrel
ATCG03AAProgestogens and estrogens, fixed combinationsATC1-4ethinyl estradiol / levonorgestrel
ATCG03ABProgestogens and estrogens, sequential preparationsATC1-4ethinyl estradiol / levonorgestrel
FDASPLD045167Progesterone CongenersCHEMhas_chemical_structurelevonorgestrel
FDASPLN0000175825EstrogenEPChas_epcethinyl estradiol
FDASPLN0000175602ProgestinEPChas_epclevonorgestrel
FDASPLN0000175832Progestin-containing Intrauterine SystemEPChas_epclevonorgestrel
FDASPLN0000000100Estrogen Receptor AgonistsMOAhas_moaethinyl estradiol
FDASPLN0000175830Inhibit Ovum FertilizationPEhas_pelevonorgestrel
MEDRTD004997Ethinyl EstradiolCHEMhas_ingredientethinyl estradiol
MEDRTD016912LevonorgestrelCHEMhas_ingredientlevonorgestrel
MEDRTD000022Abortion, SpontaneousDISEASEinduceslevonorgestrel
MEDRTD018248Adenoma, Liver CellDISEASEci_withlevonorgestrel
MEDRTD001943Breast NeoplasmsDISEASEci_withethinyl estradiol
MEDRTD001943Breast NeoplasmsDISEASEmay_treatethinyl estradiol
MEDRTD001943Breast NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD002539Cerebral Arterial DiseasesDISEASEci_withethinyl estradiol
MEDRTD002561Cerebrovascular DisordersDISEASEci_withlevonorgestrel
MEDRTD003324Coronary Artery DiseaseDISEASEci_withethinyl estradiol
MEDRTD003327Coronary DiseaseDISEASEci_withlevonorgestrel
MEDRTD003920Diabetes MellitusDISEASEci_withlevonorgestrel
MEDRTD004342Drug HypersensitivityDISEASEci_withethinyl estradiol
MEDRTD004342Drug HypersensitivityDISEASEci_withlevonorgestrel
MEDRTD016889Endometrial NeoplasmsDISEASEci_withethinyl estradiol
MEDRTD016889Endometrial NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD020773Headache DisordersDISEASEci_withlevonorgestrel
MEDRTD006349Heart Valve DiseasesDISEASEci_withlevonorgestrel
MEDRTD019584Hot FlashesDISEASEmay_treatethinyl estradiol
MEDRTD006973HypertensionDISEASEci_withlevonorgestrel
MEDRTD006973HypertensionDISEASEci_withethinyl estradiol
MEDRTD007006HypogonadismDISEASEmay_treatethinyl estradiol
MEDRTD007565JaundiceDISEASEci_withlevonorgestrel
MEDRTD007674Kidney DiseasesDISEASEci_withlevonorgestrel
MEDRTD008107Liver DiseasesDISEASEci_withethinyl estradiol
MEDRTD008107Liver DiseasesDISEASEci_withlevonorgestrel
MEDRTD008113Liver NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD008594Menopause, PrematureDISEASEmay_treatethinyl estradiol
MEDRTD008595MenorrhagiaDISEASEmay_treatethinyl estradiol
MEDRTD009376Neoplasms, Hormone-DependentDISEASEci_withethinyl estradiol
MEDRTD015663Osteoporosis, PostmenopausalDISEASEmay_preventethinyl estradiol
MEDRTD011247PregnancyDISEASEmay_preventethinyl estradiol
MEDRTD011247PregnancyDISEASEmay_preventlevonorgestrel
MEDRTD011247PregnancyDISEASEci_withlevonorgestrel
MEDRTD011247PregnancyDISEASEci_withethinyl estradiol
MEDRTD016649Primary Ovarian InsufficiencyDISEASEmay_treatethinyl estradiol
MEDRTD011471Prostatic NeoplasmsDISEASEmay_treatethinyl estradiol
MEDRTD013923ThromboembolismDISEASEci_withlevonorgestrel
MEDRTD013923ThromboembolismDISEASEci_withethinyl estradiol
MEDRTD013924ThrombophlebitisDISEASEci_withethinyl estradiol
MEDRTD013924ThrombophlebitisDISEASEci_withlevonorgestrel
MEDRTD064424Tobacco UseDISEASEci_withethinyl estradiol
MEDRTD014029Tobacco Use DisorderDISEASEci_withlevonorgestrel
MEDRTD014592Uterine HemorrhageDISEASEci_withlevonorgestrel
MEDRTN0000000100Estrogen Receptor AgonistsMOAhas_moaethinyl estradiol
MEDRTN0000000185Progestational Hormone Receptor AgonistsMOAhas_moalevonorgestrel
MEDRTN0000008311Bone Formation StimulationPEhas_peethinyl estradiol
MEDRTN0000008595Decreased Embryonic ImplantationPEhas_peethinyl estradiol
MEDRTN0000008595Decreased Embryonic ImplantationPEhas_pelevonorgestrel
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_pelevonorgestrel
MEDRTN0000178478Increased Blood PressurePEci_pelevonorgestrel
MEDRTN0000009717Inhibit OvulationPEhas_peethinyl estradiol
MEDRTN0000009717Inhibit OvulationPEhas_pelevonorgestrel
MEDRTN0000009902Vaginal Function AlterationPEhas_peethinyl estradiol
MEDRTN0000008289Aromatic hydroxylationPKhas_pkethinyl estradiol
MEDRTN0000000045Fecal ExcretionPKhas_pkethinyl estradiol
MEDRTN0000000026Hepatic MetabolismPKhas_pkethinyl estradiol
MEDRTN0000000042Renal ExcretionPKhas_pkethinyl estradiol

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA079064
CODESANDAANDA200490
CODESVUID4032278
NAMESPrescribable SynonymIntrovale 91 Day Pack
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceVeterans Health Administration National Drug File